Medical News

RSS

AbbVie's ABT-493 and ABT-530 achieve high SVR rates in GT1 chronic HCV patients who failed previous therapy with DAAs

AbbVie, a global biopharmaceutical company, today announced that 91 percent (n=20/22) of genotype 1 (GT1) chronic hepatitis C virus (HCV) infected patients who failed previous therapy with direct-acting antivirals (DAAs) achieved SVR12 with 12 weeks of ABT-493 and ABT-530 with ribavirin (RBV) in the primary intent-to-treat analysis.

15 Apr 2016

VIEKIRAX and EXVIERA achieve high SVR rates in GT1 and GT4 hepatitis C virus infected patients

AbbVie, a global biopharmaceutical company, today announced new real-world data showing 96 percent of genotype 1 (GT1) patients (n=486/505 assessable for analysis) and 100 percent (n=53/53) of genotype 4 (GT4) patients achieved sustained virologic response at 12 weeks post-treatment (SVR12).

15 Apr 2016

New classifier method may improve diagnosis of autism spectrum disorders

Many doctors and scientists think they could improve the diagnosis and understanding of autism spectrum disorders if they had reliable means to identify specific abnormalities in the brain.

15 Apr 2016

Improving body clock could protect against metabolic syndrome

Essential biological processes are managed by an internal timer or body clock. When the body clock gets out of whack, conditions such as metabolic syndrome can occur.

15 Apr 2016

Low cost technique could fabricate microfluidic devices for biomedical applications

In this work, Dr. Diana and fellow researchers propose a low cost technique able to produce microfluidic devices for biomedical applications. The most common technique to fabricate biomedical microdevices is soft-lithography. However, it is a costly and time-consuming technique. Progress in manufacturing milling tools smaller than 100 µm, has enabled the use of micromilling machines to fabricate microfluidic devices capable of performing cell separation.

15 Apr 2016

Interdisciplinary researchers to explore ethical issues of pregnant women during Zika crisis

The emerging Zika virus epidemic is bringing to light a longstanding ethical challenge in medical research: the inclusion of pregnant women. With new funding from the Wellcome Trust, an interdisciplinary team of scholars will focus on issues of ethics and research in pregnancy and women of reproductive age, beginning with the current Zika context and later expanding to general public health research.

15 Apr 2016

High dosages of antihistamines have dulling effect on genes associated with post-exercise recovery

After vigorous exercise, some 3,000 genes go to work to aid recovery by boosting muscles and blood vessels, but in the presence of high doses of antihistamines almost 27 percent of the gene response is blunted, according to University of Oregon researchers.

15 Apr 2016

Taking antibiotics in early childhood can disrupt immune system function lifelong

Scientists want to know whether taking antibiotics early in life can disrupt your immune system function lifelong.

15 Apr 2016

M10 peptide could help protect systemic sclerosis patients against fibrotic damage

The results of preclinical studies by investigators at the Medical University of South Carolina (MUSC) reported in the April 2016 issue of Translational Research suggest that the M10 peptide could help protect against fibrotic damage in patients with systemic sclerosis, particularly in those who develop interstitial lung diseases (ILD), its deadliest complication.

15 Apr 2016

New research in SIV-exposed monkeys provides insights for development of HIV prevention strategies

New research in monkeys exposed to SIV, the monkey equivalent of HIV, suggests that the virus spreads rapidly in the body and triggers early host responses that suppress antiviral immunity, thus promoting viral replication.

15 Apr 2016

Newly found mechanism of color vision illustrates why people perceive color blue in dim light

The swirling skies of Vincent Van Gogh's Starry Night illustrate a mystery that has eluded biologists for more than a century--why do we perceive the color blue in the dimly lit night sky? A newly discovered mechanism of color vision in mice might help answer this question, Caltech researchers say.

15 Apr 2016

UNIGE researchers identify PIGG gene that plays crucial role in recessive disease

The objective of genetic medicine is to analyze all the genes that make up the human genome, in order to identify as many genetic diseases as possible. Indeed, each gene variation has the potential to trigger specific defects.

15 Apr 2016

Unmet nursing care linked to higher risk of AMI readmissions for older black patients

Why are black older adults at higher risk of repeat hospital admission after a heart attack? Treatment at hospitals with higher rates of missed nursing care may be a contributing factor, reports a study in the May issue of Medical Care. The journal is published by Wolters Kluwer.

15 Apr 2016

Proliposomal ropivacaine may offer valuable new option for pain relief

A new "proliposomal" preparation of the local anesthetic drug ropivacaine may provide a valuable new option for pain relief in some clinical situations, with key advantages over other types of slow-release local anesthetics, suggest a pair of reports in Anesthesia & Analgesia.

15 Apr 2016

Harvard University scientists develop paper-based electrical sensor to monitor a person's respiration rate

A simple but effective sensor for monitoring the respiration rate of individuals has been created. Taking advantage of the hygroscopic character of ordinary paper, scientists at Harvard University have developed an electrical sensor to detect the periodic changes of humidity by breathing in and out.

15 Apr 2016

Kevin Hollinrake MP, ANTRUK CEO comment on Chancellor George Osborne's IMF speech on antibiotic resistance

Chancellor George Osborne will today warn that resistance to antibiotics will become an “even greater threat to mankind than cancer” without global action. His comments will be presented in a speech at the International Monetary Fund (IMF) meeting in Washington today, 14th April 2016.

15 Apr 2016

AstraZeneca reports new Phase I extended follow-up data on osimertinib in NSCLC patients at ELCC 2016

AstraZeneca today reported new Phase I extended follow-up data on osimertinib in both first- and second-line treatment of patients with non-small cell lung cancer (NSCLC), at the European Lung Cancer Conference (ELCC) 2016. Late-breaker presentations reinforced the efficacy and safety profile for osimertinib previously seen in the AURA clinical trials programme.

15 Apr 2016

Patients with genotype 1 chronic HCV infection achieve high SVR rates with VIEKIRAX + EXVIERA

AbbVie, a global biopharmaceutical company, today announced data showing that patients with genotype 1 (GT1) chronic hepatitis C virus (HCV) infection who received the recommended regimen of VIEKIRAX (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA (dasabuvir tablets), with or without ribavirin (RBV), achieved high sustained virologic response rates at 48 weeks post-treatment (SVR48), regardless of the presence of baseline resistance-associated variants (RAVs).

15 Apr 2016

Home screening for bowel cancer: an interview with Deborah Alsina, Chief Executive of Bowel Cancer UK

FIT (faecal immunochemical test) is a screening test for bowel cancer which detects hidden traces of blood in stools. It is now used in population screening around the world including Italy, The Netherlands, France, Ireland, New Zealand, Australia, Spain, Slovenia, Malta, Japan, parts of Canada, and Southeast Asia.

14 Apr 2016

SU2C Catalyst program to accelerate research on cancer prevention, detection and treatment

Stand Up To Cancer, the charitable initiative aimed at bringing new treatments to cancer patients quickly, today announced Catalyst, a new program that will use funding and materials from the pharmaceutical, biotechnology, diagnostic and medical devices industries to accelerate research on cancer prevention, detection and treatment.

14 Apr 2016

Medical News

AbbVie's ABT-493 and ABT-530 achieve high SVR rates in GT1 chronic HCV patients who failed previous therapy with DAAs

VIEKIRAX and EXVIERA achieve high SVR rates in GT1 and GT4 hepatitis C virus infected patients

New classifier method may improve diagnosis of autism spectrum disorders

Improving body clock could protect against metabolic syndrome

Low cost technique could fabricate microfluidic devices for biomedical applications

Interdisciplinary researchers to explore ethical issues of pregnant women during Zika crisis

High dosages of antihistamines have dulling effect on genes associated with post-exercise recovery

Taking antibiotics in early childhood can disrupt immune system function lifelong

M10 peptide could help protect systemic sclerosis patients against fibrotic damage

New research in SIV-exposed monkeys provides insights for development of HIV prevention strategies

Newly found mechanism of color vision illustrates why people perceive color blue in dim light

UNIGE researchers identify PIGG gene that plays crucial role in recessive disease

Unmet nursing care linked to higher risk of AMI readmissions for older black patients

Proliposomal ropivacaine may offer valuable new option for pain relief

Harvard University scientists develop paper-based electrical sensor to monitor a person's respiration rate

Kevin Hollinrake MP, ANTRUK CEO comment on Chancellor George Osborne's IMF speech on antibiotic resistance

AstraZeneca reports new Phase I extended follow-up data on osimertinib in NSCLC patients at ELCC 2016

Patients with genotype 1 chronic HCV infection achieve high SVR rates with VIEKIRAX + EXVIERA

Home screening for bowel cancer: an interview with Deborah Alsina, Chief Executive of Bowel Cancer UK

SU2C Catalyst program to accelerate research on cancer prevention, detection and treatment

Voltammetry and machine learning for real-time neurotransmitter detection

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

Latest News